Published in Blood Weekly, March 13th, 1995
Professor Manuel Patarroyo, who developed the vaccine SPF66, reports that World Health Organization (WHO) Director General Hiroshi Nakajima was due to sign an agreement with the Colombian government on February 23, 1995, to set up a plant in the Latin American country for the mass production of the drug.
Much of the vaccine could find its way to Africa, home to 90 percent of the total worldwide clinical malaria cases recorded every year.
Out of the 1.5 to three million malaria deaths...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.